Effects of extract from solid-state fermented cordyceps sinensis on type 2 diabetes mellitus

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Kan, Wei Chih ^a,b   Wang, Hsien Yi ^a,c   Chien, Chih Chiang ^a,b   Li, Shun Lai ^d   Chen, Yu Chun ^d   Chang, Liang Hao ^d   Cheng, Chia Hui ^d   Tsai, Wan Chen ^d   Hwang, Jyh Chang ^a   Su, Shih Bin ^a,d   Huang, Li Hsueh ^d,e   Chuu, Jiunn Jye ^d,f  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e TAINAN SIN LAU HOSPITAL   (Taiwan)

^f Wei Gong Memorial Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CHOLESTEROL; CORDYCEPS SINENSIS EXTRACT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE TOLERANCE TEST; INSULIN TOLERANCE TEST; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SOLID STATE FERMENTATION;

EID: 84863273253     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/743107     Document Type: Article

References (40)

1. Winer N., Sowers J. R., Epidemiology of diabetes Journal of Clinical Pharmacology 2004 44 4 397 405 (Pubitemid 38396785)
2. Deshpande A. D., Harris-Hayes M., Schootman M., Epidemiology of diabetes and diabetes-related complications Physical Therapy 2008 88 11 1254 1264
3. Reaven G. M., Insulin resistance, the insulin resistance syndrome, and cardiovascular disease Panminerva Medica 2005 47 4 201 210 (Pubitemid 43471964)
4. Bloomgarden Z. T., Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome Diabetes Care 2004 27 3 824 830 (Pubitemid 38280559)
5. Chen D., Wang M. W., Development and application of rodent models for type 2 diabetes Diabetes, Obesity and Metabolism 2005 7 4 307 317 (Pubitemid 40916572)
6. Islam M. S., Loots D. T., Experimental rodent models of type 2 diabetes: a review Methods and Findings in Experimental and Clinical Pharmacology 2009 31 4 249 261
7. Srinivasan K., Ramarao P., Animal models in type 2 diabetes research: an overview Indian Journal of Medical Research 2007 125 3 451 472 (Pubitemid 46805458)
8. Accili D., Kido Y., Nakae J., Lauro D., Park B. C., Genetics of type 2 diabetes: insight from targeted mouse mutants Current Molecular Medicine 2001 1 1 9 23 (Pubitemid 33772967)
9. Karasawa H., Nagata-Goto S., Takaishi K., Kumagae Y., A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice Metabolism 2009 58 3 296 303
10. Terauchi Y., Kadowaki T., Insights into molecular pathogenesis of type 2 diabetes from knockout mouse models Endocrine Journal 2002 49 3 247 263 (Pubitemid 34832295)
11. Paterson R. R. M., Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 2008 69 7 1469 1495
12. Zhou X., Gong Z., Su Y., Lin J., Tang K., Cordyceps fungi: natural products, pharmacological functions and developmental products Journal of Pharmacy and Pharmacology 2009 61 3 279 291
13. Kiho T., Hui J., Yamane A., Ukai S., Polysaccharides in Fungi. XXXII. Hypoglycemic activity and chemical properties of a polysaccharide from the cultural mycelium of Cordyceps sinensis Biological and Pharmaceutical Bulletin 1993 16 12 1291 1293 (Pubitemid 24049998)
14. Kiho T., Ookubo K., Usui S., Ukai S., Hirano K., Structural features and hypoglycemic activity of a polysaccharide (CS-F10) from the cultured mycelium of Cordyceps sinensis Biological and Pharmaceutical Bulletin 1999 22 9 966 970 (Pubitemid 29482909)
15. Guo J. Y., Han C. C., Liu Y. M., A contemporary treatment approach to both diabetes and depression by Cordyceps sinensis, Rich in Vanadium Evidence-Based Complementary and Alternative Medicine 2010 7 3 387 389
16. Lo H. C., Tu S. T., Lin K. C., Lin S. C., The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin Life Sciences 2004 74 23 2897 2908
17. Lo H. C., Hsu T. H., Tu S. T., Lin K. C., Anti-hyperglycemic activity of natural and fermented Cordyceps sinensis in rats with diabetes induced by nicotinamide and streptozotocin American Journal of Chinese Medicine 2006 34 5 819 832
18. Zhang C., Zou X., Leluo G., Xu J., Xiang M., Prevention of type 1 diabetes by immature dendritic cells treated with an ethanol extract of Paecilomyces hepiali Chen mycelium Methods and Findings in Experimental and Clinical Pharmacology 2008 30 6 421 429
19. Zhang Z., Wang X., Zhang Y., Ye G., Effect of Cordyceps sinensis on renal function of patients with chronic allograft nephropathy Urologia Internationalis 2011 86 3 298 301
20. Tang R., Zhou Q., Shu J., Tang T., Ao X., Peng W., Zhang Y., Effect of Cordyceps sinensis extract on Klotho expression and apoptosis in renal tubular epithelial cells induced by angiotensin II Journal of Central South University 2009 34 4 300 307
21. Balon T. W., Jasman A. P., Zhu J. S., A fermentation product of Cordyceps sinensis increases whole-body insulin sensitivity in rats Journal of Alternative and Complementary Medicine 2002 8 3 315 323 (Pubitemid 34753406)
22. Zhang X., Liu Y. K., Zheng Q., Shen W., Shen D. M., Influence of Cordyceps sinensis on pancreatic islet beta cells in rats with experimental liver fibrogenesis Zhonghua Gan Zang Bing Za Zhi 2003 11 2 93 94
23. Hsiao G., Chapman J., Ofrecio J. M., Wilkes J., Resnik J. L., Thapar D., Subramaniam S., Sears D. D., Multi-tissue, selective PPAR modulation of insulin sensitivity and metabolic pathways in obese rats American Journal of Physiology 2011 300 1 E164 E174
24. Balasubramanian R., Gerrard J., Dalla Man C., Firbank M. J., Lane A., English P. T., Cobelli C., Taylor R., Combination peroxisome proliferator-activated receptor and agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content Diabetic Medicine 2010 27 2 150 156
25. Mollah M. L., Kim G. S., Moon H. K., Chung S. K., Cheon Y. P., Kim J. K., Kim K. S., Antiobesity effects of wild ginseng (Panax ginseng C.A. meyer) mediated by PPAR-, GLUT4 and LPL in ob/ob mice Phytotherapy Research 2009 23 2 220 225
26. Svenson K. L., Von Smith R., Magnani P. A., Suetin H. R., Paigen B., Naggert J. K., Li R., Churchill G. A., Peters L. L., Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations Journal of Applied Physiology 2007 102 6 2369 2378 (Pubitemid 47080772)
27. Polotsky V. Y., Mouse model of the metabolic syndrome: the quest continues Journal of Applied Physiology 2007 102 6 2088 2089 (Pubitemid 47080736)
28. Qi Z., Fujita H., Jin J., Davis L. S., Wang Y., Fogo A. B., Breyer M. D., Characterization of susceptibility of inbred mouse strains to diabetic nephropathy Diabetes 2005 54 9 2628 2637 (Pubitemid 41233584)
29. Wajchenberg B. L., -cell failure in diabetes and preservation by clinical treatment Endocrine Reviews 2007 28 2 187 218 (Pubitemid 46984834)
30. Del Prato S., Pulizzi N., The place of sulfonylureas in the therapy for type 2 diabetes mellitus Metabolism 2006 55 1 S20 S27
31. Matsuda M., Kawasaki F., Mikami Y., Takeuchi Y., Saito M., Eto M., Kaku K., Rescue of beta-cell exhaustion by diazoxide after the development of diabetes mellitus in rats with streptozotocin-induced diabetes European Journal of Pharmacology 2002 453 1 141 148 (Pubitemid 35232464)
32. Walter H., Lbben G., Potential role of oral thiazolidinedione therapy in preserving -cell function in type 2 diabetes mellitus Drugs 2005 65 1 1 13 (Pubitemid 40143799)
33. Wajchenberg B. L., Clinical approaches to preserve beta-cell function in diabetes Advances in Experimental Medicine and Biology 2010 654 515 535
34. United States Renal Data System. USRDS annual data report, 2009, http://www.usrds.org
35. Raccah D., Lamotte-Jannot M. F., Issautier T., Vague P., Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney Diabete et Metabolisme 1994 20 3 271 274 (Pubitemid 24336886)
36. Tsimarato M., Coste T. C., Djemli-Shipkolye A., Daniel L., Shipkolye F., Vague P., Raccah D., Evidence of time-dependent changes in renal medullary Na,K-ATPase activity and expression in diabetic rats Cellular and Molecular Biology 2001 47 2 239 245
37. Gallicchio M. A., Bach L. A., Advanced glycation end products inhibit Na + K + ATPase in proximal tubule epithelial cells: role of cytosolic phospholipase A2 and phosphatidylinositol 4-phosphate 5-kinase Biochimica et Biophysica Acta 2010 1803 8 919 930
38. Jannot M. F., Raccah D., De La Tour D. D., Coste T., Vague P., Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients Metabolism 2002 51 3 284 291 (Pubitemid 34232627)
39. Vague P., Coste T. C., Jannot M. F., Raccah J. D., Tsimaratos M., C-peptide, Na +,K + -ATPase, and diabetes Experimental Diabesity Research 2004 5 1 37 50
40. Shahid S. M., Mahboob T., Electrolytes and Na + -K + -ATPase: potential risk factors for the development of diabetic nephropathy Pakistan Journal of Pharmaceutical Sciences 2008 21 2 172 179